2019 Cannabis Clinical Trials Download 
Cannabis Law Report
NOVEMBER 24, 2019
Cannabis-based medicinal products. NICE guideline [NG144] Published date: November 2019. Do not offer CBD to manage chronic pain in adults unless as part of a clinical trial. NICE has made research recommendations on the use of cannabis-based medicinal products for severe treatment-resistant epilepsy. Spasticity.
TheAnswerPage
JANUARY 11, 2022
As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
DECEMBER 21, 2021
All three industries are target markets from Dalrada’s original expansion plan that started in 2019. With North America accounting for the most significant portion of the global healthcare services market at 40% (2019), market analysts expect growth at a CAGR of 7%, reaching $9,725.4 billion in 2019 Q3. billion in 2023.
Project CBD
FEBRUARY 28, 2023
The combined total from both channels — $58,293,034 — does not include CBD sales in licensed cannabis dispensaries or CBD products, such as vapes, tinctures, gummies, and other edibles sold online. (E-commerce Sales appear to have peaked in 2019, when natural channel consumers spent more than $90.7 Accessed July 25, 2021.
Cannabis Law Report
JUNE 10, 2021
In short the study learns that legalized states tend not to have their roads overcrowded with stoned drivers and cannabis users like alcohol users self police their behaviour. The prevalence of cannabis-involved driving in California. Cannabis effects on driving skills. J Anal Toxicol. 2014;38(8):569–74. Drug Alcohol Depend.
Cannabis Law Report
NOVEMBER 24, 2021
Medical publications, are, in the main fairly positive toward cannabis. Published by The Journal of Cannabis Research. Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. At the same time, the outlook on cannabis research data is largely positive. Background.
Cannabis Law Report
JULY 15, 2022
The first Australian company to be licensed to cultivate and manufacture medicinal marijuana has praised the Federal Government’s plan to allow exports of cannabis-based medicines. Secrecy has surrounded a media visit to Queensland’s first licensed cannabis farm, which is nearing completion on the Sunshine Coast.
Expert insights. Personalized for you.
59 
Let's personalize your content